Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
138.16
+1.31 (0.96%)
At close: Jun 12, 2026, 4:00 PM EDT
138.79
+0.63 (0.46%)
After-hours: Jun 12, 2026, 5:34 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $5.44 billion as of June 12, 2026. Its market cap has increased by 154.43% in one year.
Market Cap
5.44B
Enterprise Value
4.94B
1-Year Change
154.43%
Ranking
Category
Stock Price
$138.16
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $5.44B, an increase of 3,659.52%. That is a compound annual growth rate of 141.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 5.44B | -9.43% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 6.20B |
| Centessa Pharmaceuticals | 6.15B |
| Mirum Pharmaceuticals | 6.07B |
| Rhythm Pharmaceuticals | 6.01B |
| Cogent Biosciences | 5.58B |
| Scholar Rock Holding | 5.36B |
| Ligand Pharmaceuticals | 5.10B |
| Caris Life Sciences | 5.09B |